MRC — Mercator Medical SA Cashflow Statement
0.000.00%
Last trade - 00:00
- PLN409.38m
- PLN247.05m
- PLN542.51m
- 38
- 68
- 41
- 44
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 7.04 | -2.03 | 936 | 445 | -191 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 5.41 | 8.48 | -13.6 | -113 | 101 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -34.8 | 14.6 | -228 | 152 | 105 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -8.21 | 38.5 | 712 | 503 | 40.8 |
Capital Expenditures | -43.1 | -15.6 | -15.5 | -177 | -110 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.125 | 0.162 | -146 | -53.3 | -37.1 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -42.9 | -15.4 | -161 | -230 | -147 |
Financing Cash Flow Items | -5.54 | -8.52 | -4.23 | -0.117 | -0.015 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 46.6 | -24.6 | -166 | -334 | -1.39 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.58 | -1.42 | 385 | -60.2 | -116 |